Quality assurance of metabolomics

Altex

Volumn 32, Issue 4, 2015, Pages 319-326

  Bouhifd, Mounir ^a   Beger, Richard ^b   Flynn, Thomas ^c   Guo, Lining ^d   Harris, Georgina ^a   Hogberg, Helena ^a   Kaddurah Daouk, Rima ^e   Kamp, Hennicke ^f   Kleensang, Andre ^a   Maertens, Alexandra ^a   Odwin DaCosta, Shelly ^a   Pamies, David ^a   Robertson, Donald ^g   Smirnova, Lena ^a   Sun, Jinchun ^b   Zhao, Liang ^a   Hartung, Thomas ^a,h  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d METABOLON INC   (United States)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BASF SE   (Germany)

^g BRISTOL MYERS SQUIBB   (United States)

^h UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

Human toxome; Metabolomics; Quality assurance; Toxicometabolomics

Indexed keywords

ARTICLE; EXTRACTION; METABOLOMICS; QUALITY CONTROL; SAMPLING; STUDY DESIGN; SYSTEMS BIOLOGY; TOXICOLOGY; TOXICOMETABOLOMICS; WORKSHOP; ANIMAL; ANIMAL TESTING ALTERNATIVE; BIOLOGICAL MODEL; PROCEDURES; STANDARDS;

ANIMAL TESTING ALTERNATIVES; ANIMALS; METABOLOMICS; MODELS, BIOLOGICAL; QUALITY CONTROL;

EID: 84946731469     PISSN: 1868596X     EISSN: 18688551     Source Type: Journal    
DOI: 10.14573/altex.1509161     Document Type: Article

References (58)

1. Balcke, G. U., Kolle, S. N., Kamp, H. et al. (2011). Linking energy metabolism to dysfunctions in mitochondrial respiration-a metabolomics in vitro approach. Toxicol Lett 203, 200-209. http://dx.doi.org/10.1016/j.toxlet.2011.03.013
2. Bouhifd, M., Hartung, T., Hogberg, H. T. et al. (2013). Review: Toxicometabolomics. J Appl Toxicol 33, 1365-1383. http://dx.doi.org/10.1002/Jat.2874
3. Bouhifd, M., Hogberg, H. T., Kleensang, A. et al. (2014). Mapping the human toxome by systems toxicology. Basic Clin Pharmacol Toxicol 115, 24-31. http://dx.doi.org/10.1111/bcpt.12198
4. Bouhifd, M., Andersen, M. E., Baghdikian, C. et al. (2015). The human toxome project. ALTEX 32, 112-124. http://dx.doi.org/10.14573/altex.1502091
5. Coecke, S., Balls, M., Bowe, G. et al. (2005). Guidance on good cell culture practice. A report of the second ECVAM task force on good cell culture practice. Altern Lab Anim 33, 261-287.
6. Corvi, R., Ahr, H. J., Albertini, S. et al. (2006). Meeting report: Validation of toxicogenomics-based test systems: ECVAM-ICCVAM/NICEATM considerations for regulatory use. Environ Health Perspect 114, 420-429. http://dx.doi.org/10.1289/ehp.8247
7. Craig, A., Sidaway, J., Holmes, E. et al. (2006). Systems toxicology: Integrated genomic, proteomic and metabonomic analysis of methapyrilene induced hepatotoxicity in the rat. J Proteome Res 5, 1586-1601. http://dx.doi.org/10.1021/pr0503376
8. Creek, D. J., Dunn, W. B., Fiehn, O. et al. (2014). Metabolite identification: Are you sure? And how do your peers gauge your confidence? Metabolomics 10, 350-353. http://dx.doi.org/10.1007/s11306-014-0656-8
9. Dunn, W. B. and Ellis, D. I. (2005). Metabolomics: Current analytical platforms and methodologies. Trac-Trends In Analytical Chemistry 24, 285-294. http://dx.doi.org/10.1016/j.trac.2004.11.021
10. Dunn, W. B., Wilson, I. D., Nicholls, A. W. et al. (2012). The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans. Bioanalysis 4, 2249-2264. http://dx.doi.org/10.4155/bio.12.204
11. Dunn, W. B., Erban, A., Weber, R. J. M. et al. (2013). Mass appeal: Metabolite identification in mass spectrometry-focused untargeted metabolomics. Metabolomics 9, S44-S66. http://dx.doi.org/10.1007/s11306-012-0434-4
12. Ellis, J. K., Athersuch, T. J., Cavill, R. et al. (2011). Metabolic response to low-level toxicant exposure in a novel renal tubule epithelial cell system. Mol Biosyst 7, 247-257. http://dx.doi.org/10.1039/c0mb00146e
13. Ferrario, D., Brustio, R. and Hartung, T. (2014). Glossary of reference terms for alternative test methods and their validation. ALTEX 31, 319-335. http://dx.doi.org/10.14573/altex.1403311
14. Gika, H. G., Theodoridis, G. A., Wingate, J. E. et al. (2007). Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: Application to human urine. J Proteome Res 6, 3291-3303. http://dx.doi.org/10.1021/pr070183p
15. Grandjean, P. and Landrigan, P. J. (2006). Developmental neurotoxicity of industrial chemicals. Lancet 368, 2167-2178. http://dx.doi.org/10.1016/S0140-6736(06)69665-7
16. Griffiths, W. J., Koal, T., Wang, Y. et al. (2010). Targeted metabolomics for biomarker discovery. Angew Chem Int Ed Engl 49, 5426-5445. http://dx.doi.org/10.1002/anie.200905579
17. Hartung, T., Balls, M., Bardouille, C. et al. (2002). Good Cell Culture Practice. ECVAM Good Cell Culture Practice Task Force Report 1. Altern Lab Anim 30, 407-414.
18. Hartung, T. (2007a). Food for thought⋯ on cell culture. ALTEX 24, 143-152. http://www.altex.ch/All-issues/Issue.50.html?iid=87&aid=1
19. Hartung, T. (2007b). Food for thought⋯ on validation. ALTEX 24, 67-80. http://www.altex.ch/All-issues/Issue.50.html?iid=86&aid=3
20. Hartung, T. (2009). Toxicology for the twenty-first century. Nature 460, 208-212. http://dx.doi.org/10.1038/460208a
21. Hartung, T. (2010). Lessons learned from alternative methods and their validation for a new toxicology in the 21st century. J Toxicol Environ Health B Crit Rev 13, 277-290. http://dx.doi.org/10.1080/10937404.2010.483945
22. Hartung, T. (2011). From alternative methods to a new toxicology. Eur J Pharm Biopharm 77, 338-349. http://dx.doi.org/10.1016/j.ejpb.2010.12.027
23. Hartung, T. and McBride, M. (2011). Food for thought⋯ on mapping the human toxome. ALTEX 28, 83-93. http://dx.doi.org/10.14573/altex.2011.2.083
24. Hartung, T., van Vliet, E., Jaworska, J. et al. (2012). Systems toxicology. ALTEX 29, 119-128. http://dx.doi.org/10.14573/altex.2012.2.119
25. Hartung, T. (2013). Look back in anger-what clinical studies tell us about preclinical work. ALTEX 30, 275-291. http://dx.doi.org/10.14573/altex.2013.3.275
26. Heijne, W. H., Kienhuis, A. S., van Ommen, B. et al. (2005). Systems toxicology: Applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology. Expert Rev Proteomics 2, 767-780. http://dx.doi.org/10.1586/14789450.2.5.767
27. Judson, R., Richard, A., Dix, D. J. et al. (2009). The toxicity data landscape for environmental chemicals. Environ Health Perspect 117, 685-695. http://dx.doi.org/10.1289/ehp.0800168
28. Kaddurah-Daouk, R., Kristal, B. S. and Weinshilboum, R. M. (2008). Metabolomics: A global biochemical approach to drug response and disease. Annu Rev Pharmacol Toxicol 48, 653-683. http://dx.doi.org/10.1146/annurev.pharmtox.48.113006.094715
29. Kleensang, A., Maertens, A., Rosenberg, M. et al. (2014). The workshop report: Pathways of toxicity. ALTEX 31, 53-61. http://dx.doi.org/10.14573/altex.1309261
30. Leist, M., Hartung, T. and Nicotera, P. (2008). The dawning of a new age of toxicology. ALTEX 25, 103-114.
31. Leist, M., Hasiwa, N., Daneshian, M. et al. (2012). Validation and quality control of replacement alternatives-current status and future challenges. Toxicol Res 1, 8-22. http://dx.doi.org/10.1039/C2tx20011b
32. Lindon, J. C., Keun, H. C., Ebbels, T. M. et al. (2005). The Consortium for Metabonomic Toxicology (COMET): Aims, activities and achievements. Pharmacogenomics 6, 691-699. http://dx.doi.org/10.2217/14622416.6.7.691
33. Maier, T. S., Kuhn, J. and Muller, C. (2010). Proposal for field sampling of plants and processing in the lab for environmental metabolic fingerprinting. Plant Methods 6, http://dx.doi.org/10.1186/1746-4811-6-6
34. Montoya, G. A., Strauss, V., Fabian, E. et al. (2014). Mechanistic analysis of metabolomics patterns in rat plasma during administration of direct thyroid hormone synthesis inhibitors or compounds increasing thyroid hormone clearance. Toxicol Lett 225, 240-251. http://dx.doi.org/10.1016/j.toxlet.2013.12.010
35. OECD (2004). Advisory document of the working group on GLP - the application of the principles of GLP to in vitro studies. Series on Principles of Good Laboratory Practice and Compliance Monitoring 14, 1-18.
36. OECD (2005). Guidance Document on the Validation and International Acceptance of New or Updated Test Methods for Hazard Assessment. Environmental Health and Safety Monograph Series on Testing and Assessment No. 34. OECD Publishing.
37. Patti, G. J., Yanes, O. and Siuzdak, G. (2012). Metabolomics: The apogee of the omics trilogy. Nat Rev Mol Cell Biol 13, 263-269. http://dx.doi.org/10.1038/Nrm3314
38. Rai, A. J., Gelfand, C. A., Haywood, B. C. et al. (2005). HUPO Plasma Proteome Project specimen collection and handling: Towards the standardization of parameters for plasma proteome samples. Proteomics 5, 3262-3277. http://dx.doi.org/10.1002/pmic.200401245
39. Ramirez, T., Daneshian, M., Kamp, H. et al. (2013). Metabolomics in toxicology and preclinical research. ALTEX 30, 209-225. http://dx.doi.org/10.14573/altex.2013.2.209
40. Robertson, D. G. and Bulera, S. J. (2000). High-throughput toxicology: Practical considerations. Curr Opin Drug Discov Devel 3, 42-47.
41. Robertson, D. G. (2005). Metabonomics in toxicology: A review. Toxicol Sci 85, 809-822. http://dx.doi.org/10.1093/toxsci/kfi102
42. Robertson, D. G. and Lindon, J. C. (2005). Metabonomics in toxicity assessment. Boca Raton, FL, USA: Taylor & Francis. http://dx.doi.org/10.1201/b14117
43. Robertson, D. G., Watkins, P. B. and Reily, M. D. (2011). Metabolomics in toxicology: Preclinical and clinical applications. Toxicol Sci 120, Suppl 1, S146-170. http://dx.doi.org/10.1093/toxsci/kfq358
44. Ruepp, S. U., Tonge, R. P., Shaw, J. et al. (2002). Genomics and proteomics analysis of acetaminophen toxicity in mouse liver. Toxicol Sci 65, 135-150. http://dx.doi.org/10.1093/toxsci/65.1.135
45. Ruiz-Aracama, A., Peijnenburg, A., Kleinjans, J. et al. (2011). An untargeted multi-technique metabolomics approach to studying intracellular metabolites of HepG2 cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. BMC Genomics 12, 251. http://dx.doi.org/10.1186/1471-2164-12-251
46. Schnackenberg, L. K., Jones, R. C., Thyparambil, S. et al. (2006). An integrated study of acute effects of valproic acid in the liver using metabonomics, proteomics, and transcriptomics platforms. OMICS 10, 1-14. http://dx.doi.org/10.1089/omi.2006.10.1
47. Schnackenberg, L. K., Sun, J. and Beger, R. D. (2009). Metabolomics in Systems Toxicology: Towards Personalized Medicine. In (eds.), General, Applied and Systems Toxicology. John Wiley & Sons, Ltd. http://dx.doi.org/10.1002/9780470744307.gat217
48. Stobbe, M. D., Houten, S. M., Jansen, G. A. et al. (2011). Critical assessment of human metabolic pathway databases: A stepping stone for future integration. BMC Syst Biol 5, 165. http://dx.doi.org/10.1186/1752-0509-5-165
49. Sumner, L. W., Amberg, A., Barrett, D. et al. (2007). Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics 3, 211-221. http://dx.doi.org/10.1007/s11306-007-0082-2
50. Teahan, O., Gamble, S., Holmes, E. et al. (2006). Impact of analytical bias in metabonomic studies of human blood serum and plasma. Anal Chem 78, 4307-4318. http://dx.doi.org/10.1021/ac051972y
51. van Ravenzwaay, B., Herold, M., Kamp, H. et al. (2012). Metabolomics: A tool for early detection of toxicological effects and an opportunity for biology based grouping of chemicals-from QSAR to QBAR. Mutat Res 746, 144-150. http://dx.doi.org/10.1016/j.mrgentox.2012.01.006
52. van Ravenzwaay, B., Peter, E., Krennrich, G. et al. (in press). The development of a data base for metabolomics-looking back on 10 years of experience.
53. van Vliet, E., Morath, S., Eskes, C. et al. (2008). A novel in vitro metabolomics approach for neurotoxicity testing, proof of principle for methyl mercury chloride and caffeine. Neurotoxicology 29, 1-12. http://dx.doi.org/10.1016/j.neuro.2007.09.007
54. Vulimiri, S. V., Misra, M., Hamm, J. T. et al. (2009). Effects of mainstream cigarette smoke on the global metabolome of human lung epithelial cells. Chem Res Toxicol 22, 492-503. http://dx.doi.org/10.1021/tx8003246
55. Winder, C. L., Dunn, W. B., Schuler, S. et al. (2008). Global metabolic profiling of Escherichia coli cultures: An evaluation of methods for quenching and extraction of intracellular metabolites. Anal Chem 80, 2939-2948. http://dx.doi.org/10.1021/Ac7023409
56. Wishart, D. S., Knox, C., Guo, A. C. et al. (2009). HMDB: A knowledgebase for the human metabolome. Nucleic Acids Res 37, D603-610. http://dx.doi.org/10.1093/nar/gkn810
57. Wishart, D. S. (2011). Advances in metabolite identification. Bioanalysis 3, 1769-1782. http://dx.doi.org/10.4155/Bio.11.155
58. Zhou, B., Xiao, J. F., Tuli, L. et al. (2012). LC-MS-based metabolomics. Mol Biosyst 8, 470-481. http://dx.doi.org/10.1039/c1mb05350g